株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

結核診断市場:世界の業界動向、市場シェア・規模・成長率・機会・将来予測 (2020~2025年)

Tuberculosis Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

発行 IMARC Services Private Limited 商品コード 945215
出版日 ページ情報 英文 110 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=108.31円で換算しております。
結核診断市場:世界の業界動向、市場シェア・規模・成長率・機会・将来予測 (2020~2025年) Tuberculosis Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025
出版日: 2020年06月18日 ページ情報: 英文 110 Pages
概要

世界の結核診断市場は、2020~2025年に約3%のCAGRで成長する、と予測されています。 市場成長の主な要因として、高齢者人口の増加や医療費の増大、政府の支援策、研究開発 (R&D) 投資の拡大などが挙げられます。

当レポートでは、世界の結核診断市場の構造と動向について分析し、市場の全体的構造や、市場規模の推移・予測、病期別・検査の種類別・エンドユーザー別・地域別の詳細動向、市場の求心力・競争情勢、主要企業のプロファイルなどについて調査しております。

第1章 序論

第2章 分析範囲・手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の血行動態モニタリング市場

  • 市場概要
  • 市場規模の実績値

第6章 病期別の市場区分

  • 潜在性結核
  • 活動性結核

第7章 検査の種類別の市場区分

  • X線検査
  • 検査室診断
    • 主な種類
  • 核酸検査
  • サイトカイン検出試験
  • 薬剤耐性試験
  • その他

第8章 エンドユーザー別の市場区分

  • 病院・診療所
  • 診断検査室・調査
  • その他

第9章 地域別の市場区分

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場分析:国別

第10章 SWOT分析

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

第13章 価格指標

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Alere Inc.
    • Becton Dickinson and Company
    • BioMerieux
    • Cepheid Inc.
    • Epistem Ltd.
    • Roche Holding AG
    • Hain Lifescience GmbH
    • Hologic Inc.
    • QIAGEN GmbH
    • Siemens
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Tuberculosis Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Tuberculosis Diagnostics Market: Sales Value (in Billion US$), 2014-2019
  • Figure 3: Global: Tuberculosis Diagnostics Market: Breakup by Disease Stage (in %), 2019
  • Figure 4: Global: Tuberculosis Diagnostics Market: Breakup by Test Type (in %), 2019
  • Figure 5: Global: Tuberculosis Diagnostics Market: Breakup by End-User (in %), 2019
  • Figure 6: Global: Tuberculosis Diagnostics Market: Breakup by Region (in %), 2019
  • Figure 7: Global: Tuberculosis Diagnostics Market Forecast: Sales Value (in Billion US$), 2020-2025
  • Figure 8: Global: Tuberculosis Diagnostics (Latent TB) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 9: Global: Tuberculosis Diagnostics (Latent TB) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 10: Global: Tuberculosis Diagnostics (Active TB) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 11: Global: Tuberculosis Diagnostics (Active TB) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 12: Global: Tuberculosis Diagnostics (Radiographic Test) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 13: Global: Tuberculosis Diagnostics (Radiographic Test) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 14: Global: Tuberculosis Diagnostics (Laboratory Test) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 15: Global: Tuberculosis Diagnostics (Laboratory Test) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 16: Global: Tuberculosis Diagnostics (Nucleic Acid Testing) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 17: Global: Tuberculosis Diagnostics (Nucleic Acid Testing) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 18: Global: Tuberculosis Diagnostics (Cytokine Detection Test) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 19: Global: Tuberculosis Diagnostics (Cytokine Detection Test) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 20: Global: Tuberculosis Diagnostics (Drug Resistance Test) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 21: Global: Tuberculosis Diagnostics (Drug Resistance Test) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 22: Global: Tuberculosis Diagnostics (Others) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 23: Global: Tuberculosis Diagnostics (Others) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 24: Global: Tuberculosis Diagnostics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 25: Global: Tuberculosis Diagnostics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 26: Global: Tuberculosis Diagnostics (Diagnostics and Research Laboratories) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 27: Global: Tuberculosis Diagnostics (Diagnostics and Research Laboratories) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 28: Global: Tuberculosis Diagnostics (Other End-Users) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 29: Global: Tuberculosis Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 30: North America: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 31: North America: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 32: United States: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 33: United States: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 34: Canada: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 35: Canada: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 36: Asia Pacific: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 37: Asia Pacific: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 38: China: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 39: China: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 40: Japan: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 41: Japan: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 42: India: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 43: India: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 44: South Korea: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 45: South Korea: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 46: Australia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 47: Australia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 48: Indonesia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 49: Indonesia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 50: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 51: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 52: Europe: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 53: Europe: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 54: Germany: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 55: Germany: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 56: France: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 57: France: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 58: United Kingdom: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 59: United Kingdom: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 60: Italy: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 61: Italy: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 62: Spain: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 63: Spain: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 64: Russia: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 65: Russia: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 66: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 67: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 68: Latin America: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 69: Latin America: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 70: Brazil: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 71: Brazil: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 72: Mexico: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 73: Mexico: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 74: Others: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 75: Others: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 76: Middle East and Africa: Tuberculosis Diagnostics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 77: Middle East and Africa: Tuberculosis Diagnostics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 78: Global: Tuberculosis Diagnostics Industry: SWOT Analysis
  • Figure 79: Global: Tuberculosis Diagnostics Industry: Value Chain Analysis
  • Figure 80: Global: Tuberculosis Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Tuberculosis Diagnostics Market: Key Industry Highlights, 2019 and 2025
  • Table 2: Global: Tuberculosis Diagnostics Market Forecast: Breakup by Disease Stage (in Million US$), 2020-2025
  • Table 3: Global: Tuberculosis Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2020-2025
  • Table 4: Global: Tuberculosis Diagnostics Market Forecast: Breakup by End-User (in Million US$), 2020-2025
  • Table 5: Global: Tuberculosis Diagnostics Market Forecast: Breakup by Region (in Million US$), 2020-2025
  • Table 6: Global: Tuberculosis Diagnostics Market: Competitive Structure
  • Table 7: Global: Tuberculosis Diagnostics Market: Key Players
目次
Product Code: SR1019J16_Report

The global tuberculosis diagnostics market is currently witnessing strong growth. Tuberculosis (TB) refers to an infectious bacterial disease that primarily affects the lungs (pulmonary), along with other parts of the body (extrapulmonary). The infection is diagnosed via a Mantoux tuberculin skin test (TST) or the TB blood test. Additional tests are required to confirm TB disease, depending on the infected organs. In the case of pulmonary TB, chest radiography is performed for detecting chest abnormalities, along with acid-fast staining and microscopic examination of the patient's sputum. Extrapulmonary TB can be diagnosed using CT, MRI or ultrasound scans, endoscopy, laparoscopy, urine and blood tests, biopsies, and lumbar punctures.

The increasing prevalence of multi-drug resistant (MDR) tuberculosis across the globe is one of the key factors driving the growth of the market. MDR tuberculosis is caused by bacteria that are resistant to isoniazid and rifampicin, which are considered to be among the most potent antimicrobial drugs for TB. Furthermore, the availability of technologically advanced Point-of-Care (POC) diagnostic methods is also providing a boost to the market growth. Advanced diagnostic methods, such as Nucleic acid amplification tests (NAATs) and Interferon-Gamma Release Assay (IGRA), are more accurate, convenient, and provide prompt results in comparison to the traditionally used techniques. Additionally, significant improvements in the healthcare infrastructure, along with the growing awareness among the masses about various diagnostic procedures, are acting as another growth-inducing factor. Other factors, including the rising geriatric population and increasing healthcare expenditure and government initiatives and investments to promote research and development (R&D) activities, are projected to drive the market further. Looking forward, IMARC Group expects the market to register a CAGR of around 3% during 2020-2025.

Breakup by Disease Stage:

  • Latent TB
  • Active TB

Breakup by Test Type:

  • Radiographic Test
  • Laboratory Test
  • Smear Microscopy
  • Culture-based Test
  • Nucleic Acid Testing
  • Cytokine Detection Test
  • Drug Resistance Test
  • Others

Breakup by End-User:

  • Hospitals and Clinics
  • Diagnostics and Research Laboratories
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Alere Inc., Becton Dickinson and Company, BioMerieux, Cepheid Inc., Epistem Ltd., Roche Holding AG, Hain Lifescience GmbH, Hologic Inc., QIAGEN GmbH, Siemens, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report:

  • How has the global tuberculosis diagnostics market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What is the breakup of the market based on the disease stage?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global tuberculosis diagnostics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Tuberculosis Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Market Forecast

6 Market Breakup by Disease Stage

  • 6.1 Latent TB
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Active TB
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Radiographic Test
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Laboratory Test
    • 7.2.1 Market Trends
    • 7.2.2 Major Types
      • 7.2.2.1 Smear Microscopy
      • 7.2.2.2 Culture-based Test
    • 7.2.3 Market Forecast
  • 7.3 Nucleic Acid Testing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cytokine Detection Test
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Drug Resistance Test
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostics and Research Laboratories
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Alere Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Becton Dickinson and Company
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 BioMerieux
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Cepheid Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 Epistem Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Roche Holding AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Hain Lifescience GmbH
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Hologic Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 QIAGEN GmbH
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Siemens
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis